Literature DB >> 15568815

Transcription-dependent polyubiquitination of RNA polymerase II requires lysine 63 of ubiquitin.

Keng Boon Lee1, Phillip A Sharp.   

Abstract

Lysine-63-linked polyubiquitin chains are not thought to signal protein degradation but instead signal for a variety of cellular processes including some types of DNA repair. RNA polymerase (Pol) II is polyubiquitinated following DNA damage or upon treatment of nuclear extracts with the transcription inhibitor alpha-amanitin. Here, we report, using a reaction in vitro, that transcription-dependent polyubiquitination of RNA Pol II consists of lysine-63-linked chains. This modification is specific for RNA Pol II engaged in active transcription and arrested by alpha-amanitin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568815     DOI: 10.1021/bi048719x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?

Authors:  Olivier Bensaude
Journal:  Transcription       Date:  2011-05

2.  The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress.

Authors:  Olga Mikhaylova; Monika L Ignacak; Teresa J Barankiewicz; Svetlana V Harbaugh; Ying Yi; Patrick H Maxwell; Martin Schneider; Katie Van Geyte; Peter Carmeliet; Monica P Revelo; Michael Wyder; Kenneth D Greis; Jarek Meller; Maria F Czyzyk-Krzeska
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

3.  A Molecular Toolkit to Visualize Native Protein Assemblies in the Context of Human Disease.

Authors:  Brian L Gilmore; Carly E Winton; Andrew C Demmert; Justin R Tanner; Sam Bowman; Vasilea Karageorge; Kaya Patel; Zhi Sheng; Deborah F Kelly
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

4.  Degradation of DNA damage-independently stalled RNA polymerase II is independent of the E3 ligase Elc1.

Authors:  Eleni Karakasili; Cornelia Burkert-Kautzsch; Anja Kieser; Katja Sträßer
Journal:  Nucleic Acids Res       Date:  2014-08-12       Impact factor: 16.971

5.  A microchip platform for structural oncology applications.

Authors:  Carly E Winton; Brian L Gilmore; Andrew C Demmert; Vasilea Karageorge; Zhi Sheng; Deborah F Kelly
Journal:  NPJ Breast Cancer       Date:  2016-06-15

6.  Hsc70 focus formation at the periphery of HSV-1 transcription sites requires ICP27.

Authors:  Ling Li; Lisa A Johnson; Jenny Q Dai-Ju; Rozanne M Sandri-Goldin
Journal:  PLoS One       Date:  2008-01-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.